# PRETELL: PREvention of TELomere-related Complications After Lung Transplant

> **NCT04807309** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Short Telomere Length
- Lung Transplant

## Interventions

- **DRUG:** Danazol Pill
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04807309
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01-01
- **Primary completion:** 2021-11-20
- **Final completion:** 2022-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of financial support
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04807309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04807309, "PRETELL: PREvention of TELomere-related Complications After Lung Transplant". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04807309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*